TPO-RAs and ITP remission: cause or coincidence?
Blood · 08.06.2023 · 141 (23) · 2790-2791
DOI: 10.1182/blood.2023020243 ↗Kurz gefasst
Editorial in der Zeitschrift Blood, erschienen am 08.06.2023. Verfasst von Kristen M Sanfilippo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine St. Louis. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
In this issue of Blood, Guillet et al report high rates of sustained platelet response following discontinuation of thrombopoietin receptor agonist (TPO-RA) therapy in adult patients with persistent or chronic immune thrombocytopenia (ITP) and a documented complete response (platelet count > 100 × 10 9 /L). 1Second-line treatment options for ITP include rituximab, splenectomy, and TPO-RAs.In the absence of clinical trials directly comparing these strategies, the choice of treatment is guided by patient values and preferences.Patients who value avoidance of surgery and/or immunosuppression and do not mind taking a regular medication can be considered for TPO-RA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Washington University School of Medicine St. Louis.
- John Cochran St. Louis Veterans Administration Medical Center.
- Perelman School of Medicine.
ORCID-Profile: Kristen M Sanfilippo, Adam Cuker
Zitieren
APA
Sanfilippo, K. M., & Cuker, A. (2023). TPO-RAs and ITP remission: cause or coincidence?. Blood, 141(23), 2790-2791. https://doi.org/10.1182/blood.2023020243
Vancouver
Sanfilippo KM, Cuker A. TPO-RAs and ITP remission: cause or coincidence?. Blood. 2023;141(23):2790-2791. doi:10.1182/blood.2023020243
BibTeX
@article{Sanfilippo2023,
author = {Sanfilippo, Kristen M and Cuker, Adam},
title = {TPO-RAs and ITP remission: cause or coincidence?},
journal = {Blood},
year = {2023},
volume = {141},
number = {23},
pages = {2790--2791},
doi = {10.1182/blood.2023020243}
}
EUVIMED